Psychiatric features in NMDAR and LGI1 antibody-associated autoimmune encephalitis
- PMID: 37029805
- DOI: 10.1007/s00406-023-01606-w
Psychiatric features in NMDAR and LGI1 antibody-associated autoimmune encephalitis
Abstract
Patients with autoimmune encephalitis (AE) often developed psychiatric features during the disease course. Many studies focused on the psychiatric characteristic in anti-NMDAR encephalitis (NMDAR-E), but anti-LGI1 encephalitis (LGI1-E) had received less attention regarding the analysis of psychiatric features, and no study compared psychiatric characteristic between these two groups. The clinical data of AE patients (62 NMDAR-E and 20 LGI1-E) who developed psychiatric symptoms were analyzed in this study. In NMDAR-E, the most common higher-level feature was "behavior changes" (60/62, 96.8%) and the lower-level feature "incoherent speech" was observed in 33 patients (33/62, 53.2%), followed by "agitation" (29/62, 46.8%) and "incongruent laughter/crying" (20/62, 32.3%). Similar to NMDAR-E, "behavior changes" was most common in LGI1-E (17/20, 85.0%), but the features of suicidality, eating, and obsessive-compulsive were not reported. The top three lower-level features were visual hallucinations (9/20, 45.0%), incoherent speech (8/20, 40.0%), and mood instability (7/20, 35.0%). The comparative study found that "incongruent laughter/crying", in lower-level features, was more frequently observed in NMDAR-E (32.3% vs. 0%, p = 0.002). Moreover, the Bush Francis Catatonia Rating Scale (BFCRS) assessing the catatonic symptoms in NMDAR-E were higher than LGI1-E, but the 18 item-Brief Psychiatric Rating Scale (BPRS-18) showed no difference in the two groups. In summary, both NMDAR-E and LGI1-E often developed psychiatric symptoms. In contrast with LGI1-E, the psychiatric feature "incongruent laughter/crying" was more frequently associated with NMDAR-E, and catatonic symptoms were more severe in NMDAR-E.
Keywords: Anti-LGI1 encephalitis; Anti-NMDAR encephalitis; Catatonic symptoms; Crying; Incongruent laughter; Psychiatric symptoms.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABAB R encephalitis.Ann Clin Transl Neurol. 2020 Aug;7(8):1392-1399. doi: 10.1002/acn3.51137. Epub 2020 Jul 25. Ann Clin Transl Neurol. 2020. PMID: 32710704 Free PMC article.
-
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2.J Neurol. 2025 Mar 25;272(4):287. doi: 10.1007/s00415-025-13032-0. J Neurol. 2025. PMID: 40131535 Free PMC article.
-
CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis.Neurol Neuroimmunol Neuroinflamm. 2021 Oct 25;8(6):e1086. doi: 10.1212/NXI.0000000000001086. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34697224 Free PMC article.
-
Efgartigimod treatment for therapy-refractory autoimmune encephalitis with coexistent NMDAR and LGI1 antibodies: a case report and literature review.Neurol Sci. 2025 May;46(5):1995-2005. doi: 10.1007/s10072-024-07843-8. Epub 2025 Jan 17. Neurol Sci. 2025. PMID: 39820999 Free PMC article. Review.
-
Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.Mediators Inflamm. 2017;2017:6361479. doi: 10.1155/2017/6361479. Epub 2017 Jun 18. Mediators Inflamm. 2017. PMID: 28698711 Free PMC article. Review.
Cited by
-
Mapping the global research landscape and trends of autoimmune encephalitis: A bibliometric analysis.Heliyon. 2024 Feb 17;10(4):e26653. doi: 10.1016/j.heliyon.2024.e26653. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38434060 Free PMC article.
-
Study on clinical features and factors related to long-term outcomes of antibody-negative autoimmune encephalitis.Ann Clin Transl Neurol. 2024 May;11(5):1325-1337. doi: 10.1002/acn3.52049. Epub 2024 Apr 21. Ann Clin Transl Neurol. 2024. PMID: 38644648 Free PMC article.
References
-
- Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133:2734–2748 - DOI - PubMed - PMC
-
- Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091–1098. https://doi.org/10.1016/S1474-4422(08)70224-2 - DOI - PubMed - PMC
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical